Peter Mac’s Neuroendocrine Tumour (NET) Unit has grown in number of dedicated personnel, and its Centre of Excellence status has been formally extended.
The NET unit is the leading site in the Southern Hemisphere for the treatment of these complex tumours, and it sees patients primarily from across Australia as well as New Zealand and South East Asia.
It was the first outside of Europe to be granted “Neuroendocrine Cancer Centre of Excellence” status from the European Neuroendocrine Tumor Society (ENETS), in 2018 then led by Professor Rod Hicks and Professor Michael Michael.
This involved an extensive documentation process and external audit by the ENETS, which indicated the provision of high quality multidisciplinary care for patients with NET. Following a scheduled review, the ENETS has now extended this accreditation fully for another two years.